71 related articles for article (PubMed ID: 17614163)
1. Low-density lipoprotein receptor-related protein 8 gene polymorphisms and dementia.
Helbecque N; Cottel D; Amouyel P
Neurobiol Aging; 2009 Feb; 30(2):266-71. PubMed ID: 17614163
[TBL] [Abstract][Full Text] [Related]
2. Alpha2-macroglobulin, lipoprotein receptor-related protein and lipoprotein receptor-associated protein and the genetic risk for developing Alzheimer's disease.
Depboylu C; Lohmüller F; Du Y; Riemenschneider M; Kurz A; Gasser T; Müller U; Dodel RC
Neurosci Lett; 2006 Jun; 400(3):187-90. PubMed ID: 16650578
[TBL] [Abstract][Full Text] [Related]
3. No association between the very low density lipoprotein receptor gene and late-onset Alzheimer's disease nor interaction with the apolipoprotein E gene in population-based and clinic samples.
Fallin D; Gauntlett AC; Scibelli P; Cai X; Duara R; Gold M; Crawford F; Mullan M
Genet Epidemiol; 1997; 14(3):299-305. PubMed ID: 9181358
[TBL] [Abstract][Full Text] [Related]
4. Genetic interaction between tau and the apolipoprotein E receptor LRP1 Increases Alzheimer's disease risk.
Vázquez-Higuera JL; Mateo I; Sánchez-Juan P; Rodríguez-Rodríguez E; Pozueta A; Infante J; Berciano J; Combarros O
Dement Geriatr Cogn Disord; 2009; 28(2):116-20. PubMed ID: 19684401
[TBL] [Abstract][Full Text] [Related]
5. Association study of the paraoxonase 1 gene with the risk of developing Alzheimer's disease.
Chapuis J; Boscher M; Bensemain F; Cottel D; Amouyel P; Lambert JC
Neurobiol Aging; 2009 Jan; 30(1):152-6. PubMed ID: 17624629
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of APOE and LRP genes in Brazilian individuals with Alzheimer disease.
Bahia VS; Kok F; Marie SN; Shinjo SO; Caramelli P; Nitrini R
Alzheimer Dis Assoc Disord; 2008; 22(1):61-5. PubMed ID: 18317248
[TBL] [Abstract][Full Text] [Related]
7. Lack of interaction between LRP1 and A2M polymorphisms for the risk of Alzheimer disease.
Bruno E; Quattrocchi G; Nicoletti A; Le Pira F; Maci T; Mostile G; Andreoli V; Quattrone A; Zappia M
Neurosci Lett; 2010 Sep; 482(2):112-6. PubMed ID: 20637261
[TBL] [Abstract][Full Text] [Related]
8. Association study and meta-analysis of low-density lipoprotein receptor related protein in Alzheimer's disease.
Pritchard A; Harris J; Pritchard CW; St Clair D; Lemmon H; Lambert JC; Chartier-Harlin MC; Hayes A; Thaker U; Iwatsubo T; Mann DM; Lendon C
Neurosci Lett; 2005 Jul; 382(3):221-6. PubMed ID: 15925094
[TBL] [Abstract][Full Text] [Related]
9. APOE promoter polymorphisms do not confer independent risk for Alzheimer's disease in a French population.
Zurutuza L; Verpillat P; Raux G; Hannequin D; Puel M; Belliard S; Michon A; Pothin Y; Camuzat A; Penet C; Martin C; Brice A; Campion D; Clerget-Darpoux F; Frebourg T
Eur J Hum Genet; 2000 Sep; 8(9):713-6. PubMed ID: 10980578
[TBL] [Abstract][Full Text] [Related]
10. [Genetics of late-onset Alzheimer's disease: vascular risk and beta-amyloid metabolism].
Panza F; Solfrizzi V; D'Introno A; Capurso C; Colacicco AM; Torres F; Altomare E; Capurso A
Recenti Prog Med; 2002 Sep; 93(9):489-97. PubMed ID: 12355988
[TBL] [Abstract][Full Text] [Related]
11. Association of prostaglandin-endoperoxide synthase 2 (PTGS2) polymorphisms and Alzheimer's disease in Chinese.
Ma SL; Tang NL; Zhang YP; Ji LD; Tam CW; Lui VW; Chiu HF; Lam LC
Neurobiol Aging; 2008 Jun; 29(6):856-60. PubMed ID: 17234302
[TBL] [Abstract][Full Text] [Related]
12. Variations in the APP gene promoter region and risk of Alzheimer disease.
Guyant-Maréchal L; Rovelet-Lecrux A; Goumidi L; Cousin E; Hannequin D; Raux G; Penet C; Ricard S; Macé S; Amouyel P; Deleuze JF; Frebourg T; Brice A; Lambert JC; Campion D
Neurology; 2007 Feb; 68(9):684-7. PubMed ID: 17325276
[TBL] [Abstract][Full Text] [Related]
13. EEG alterations in non-demented individuals related to apolipoprotein E genotype and to risk of Alzheimer disease.
Ponomareva NV; Korovaitseva GI; Rogaev EI
Neurobiol Aging; 2008 Jun; 29(6):819-27. PubMed ID: 17293007
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase 3 haplotypes and dementia and Alzheimer's disease. The Rotterdam Study.
Reitz C; van Rooij FJ; de Maat MP; den Heijer T; Hofman A; Witteman JC; Breteler MM
Neurobiol Aging; 2008 Jun; 29(6):874-81. PubMed ID: 17316907
[TBL] [Abstract][Full Text] [Related]
15. Role of BDNF Val66Met functional polymorphism in Alzheimer's disease-related depression.
Borroni B; Archetti S; Costanzi C; Grassi M; Ferrari M; Radeghieri A; Caimi L; Caltagirone C; Di Luca M; Padovani A;
Neurobiol Aging; 2009 Sep; 30(9):1406-12. PubMed ID: 18179845
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms and haplotypes in the C-reactive protein gene and risk of dementia.
van Oijen M; de Maat MP; Kardys I; de Jong FJ; Hofman A; Koudstaal PJ; Witteman JC; Breteler MM
Neurobiol Aging; 2007 Sep; 28(9):1361-6. PubMed ID: 16854501
[TBL] [Abstract][Full Text] [Related]
17. Genetic association of the very low density lipoprotein (VLDL) receptor gene with sporadic Alzheimer's disease.
Okuizumi K; Onodera O; Namba Y; Ikeda K; Yamamoto T; Seki K; Ueki A; Nanko S; Tanaka H; Takahashi H; Oyanagi K; Mizusawa H; Kanazawa I; Tsuji S
Nat Genet; 1995 Oct; 11(2):207-9. PubMed ID: 7550352
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-18 promoter polymorphisms and risk of late onset Alzheimer's disease.
Yu JT; Tan L; Song JH; Sun YP; Chen W; Miao D; Tian Y
Brain Res; 2009 Feb; 1253():169-75. PubMed ID: 19073159
[TBL] [Abstract][Full Text] [Related]
19. Association between somatostatin gene polymorphisms and sporadic Alzheimer's disease in Chinese population.
Xue S; Jia L; Jia J
Neurosci Lett; 2009 Nov; 465(2):181-3. PubMed ID: 19733630
[TBL] [Abstract][Full Text] [Related]
20. Age-dependent association of KIBRA genetic variation and Alzheimer's disease risk.
Rodríguez-Rodríguez E; Infante J; Llorca J; Mateo I; Sánchez-Quintana C; García-Gorostiaga I; Sánchez-Juan P; Berciano J; Combarros O
Neurobiol Aging; 2009 Feb; 30(2):322-4. PubMed ID: 17707552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
